- Home
- DSM vs ANGO Comparison
DSM vs ANGO Comparison
Compare DSM & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSM
- ANGO
- Stock Information
- Founded
- DSM 1989
- ANGO 1988
- Country
- DSM United States
- ANGO United States
- Employees
- DSM N/A
- ANGO N/A
- Industry
- DSM Investment Managers
- ANGO Medical/Dental Instruments
- Sector
- DSM Finance
- ANGO Health Care
- Exchange
- DSM Nasdaq
- ANGO Nasdaq
- Market Cap
- DSM 289.7M
- ANGO 401.4M
- IPO Year
- DSM N/A
- ANGO 2004
- Fundamental
- Price
- DSM $5.89
- ANGO $10.02
- Analyst Decision
- DSM
- ANGO Strong Buy
- Analyst Count
- DSM 0
- ANGO 3
- Target Price
- DSM N/A
- ANGO $13.00
- AVG Volume (30 Days)
- DSM 161.7K
- ANGO 552.5K
- Earning Date
- DSM 01-01-0001
- ANGO 04-02-2025
- Dividend Yield
- DSM 3.97%
- ANGO N/A
- EPS Growth
- DSM N/A
- ANGO N/A
- EPS
- DSM N/A
- ANGO N/A
- Revenue
- DSM N/A
- ANGO $286,498,000.00
- Revenue This Year
- DSM N/A
- ANGO N/A
- Revenue Next Year
- DSM N/A
- ANGO $6.63
- P/E Ratio
- DSM N/A
- ANGO N/A
- Revenue Growth
- DSM N/A
- ANGO N/A
- 52 Week Low
- DSM $4.69
- ANGO $5.26
- 52 Week High
- DSM $6.05
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- DSM 50.35
- ANGO 54.84
- Support Level
- DSM $5.75
- ANGO $9.34
- Resistance Level
- DSM $5.93
- ANGO $9.84
- Average True Range (ATR)
- DSM 0.05
- ANGO 0.45
- MACD
- DSM -0.00
- ANGO 0.15
- Stochastic Oscillator
- DSM 55.36
- ANGO 96.79
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.